RxDoctor Payments Data

Lloyd Fruge, MD

Family Medicine · Atlanta, TXNPI 1275547242

Payments from drug & device makers

$948in general payments, 2019–2025

Across 59 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$141
  • AbbVie$123
  • Astellas Pharma US Inc$110
  • Amgen$105
  • Pfizer$56
  • E.r. Squibb & Sons, L.L.C.$53
  • plus $359 from 15 others

What the payments were for

  • Food & beverage$948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$23,692
Medicare patients
255
Services billed
2,191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban232$209,968
FarxigaDapagliflozin Propanediol130$104,817
JardianceEmpagliflozin58$52,502
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$50,019
JanuviaSitagliptin Phosphate44$41,162
MounjaroTirzepatide37$36,482
XareltoRivaroxaban22$23,679
OzempicSemaglutide25$22,688
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$17,162
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog32$15,777
EntrestoSacubitril/Valsartan12$13,384
Breo ElliptaFluticasone/Vilanterol24$11,843
Potassium Chloride295$6,952
Metoprolol Succinate373$6,566
LinzessLinaclotide12$6,302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$209,968232 claims
Boehringer IngelheimJardiance$14$52,50258 claims
Johnson & JohnsonXarelto$30$23,67922 claims
Novo NordiskOzempic$45$22,68825 claims
NovartisEntresto$36$13,38412 claims
AbbVieLinzess$123$6,30212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Atlanta

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →